Africa: Gene-Editing Breakthrough – UCT in Landmark Trial
In a ground-breaking first for South Africa and the African continent, local patients are participating in a pioneering international gene-editing clinical trial that may revolutionise treatment for hereditary angioedema (HAE), a rare and potentially fatal genetic disorder. The clinical trial, now under way at the University of Cape Town’s (UCT) Lung Institute, uses CRISPR-Cas9 gene-editing…